Verfügbarkeit: Therapeutic proteins

Therapeutic proteins: strategies to modulate their plasma half-lives

Gespeichert in:

Bibliographische Detailangaben
Format:	Elektronisch E-Book
Sprache:	English
Veröffentlicht:	Weinheim, Germany Wiley-Blackwell 2012
Schlagworte:	Protein drugs > Design Proteins > Therapeutic use Proteine Arzneimittelstabilität Biopharmazie Abbaureaktion Arzneimittel Aufsatzsammlung
Beschreibung:	Includes bibliographical references and index
Beschreibung:	xviii, 354 p.
ISBN:	9783527328499 9783527644797

Internformat

MARC


LEADER	00000nmm a2200000zc 4500
001	BV044162172
003	DE-604
005	00000000000000.0
007	cr\|uuu---uuuuu
008	170217s2012 \|\|\|\| o\|\|u\| \|\|\|\|\|\|eng d
020			\|a 9783527328499 \|9 978-3-527-32849-9
020			\|a 9783527644797 \|c Online \|9 978-3-527-64479-7
035			\|a (ZDB-30-PAD)EBC851166
035			\|a (ZDB-89-EBL)EBL851166
035			\|a (OCoLC)775871780
035			\|a (DE-599)BVBBV044162172
040			\|a DE-604 \|b ger \|e aacr
041	0		\|a eng
082	0		\|a 615.3
245	1	0	\|a Therapeutic proteins \|b strategies to modulate their plasma half-lives \|c edited by by Roland Kontermann
264		1	\|a Weinheim, Germany \|b Wiley-Blackwell \|c 2012
300			\|a xviii, 354 p.
336			\|b txt \|2 rdacontent
337			\|b c \|2 rdamedia
338			\|b cr \|2 rdacarrier
500			\|a Includes bibliographical references and index
505	0		\|a pt. 1. General information -- pt. 2. Half-life extension through chemical and post-translational modifications -- pt. 3. Half-life modulation involving recycling by the neonatal Fc receptor -- pt. 4. Half-life extension with pharmaceutical formulations
650		4	\|a Protein drugs \|x Design
650		4	\|a Proteins \|x Therapeutic use
650	0	7	\|a Proteine \|0 (DE-588)4076388-2 \|2 gnd \|9 rswk-swf
650	0	7	\|a Arzneimittelstabilität \|0 (DE-588)4122835-2 \|2 gnd \|9 rswk-swf
650	0	7	\|a Biopharmazie \|0 (DE-588)4006890-0 \|2 gnd \|9 rswk-swf
650	0	7	\|a Abbaureaktion \|0 (DE-588)4136352-8 \|2 gnd \|9 rswk-swf
650	0	7	\|a Arzneimittel \|0 (DE-588)4003115-9 \|2 gnd \|9 rswk-swf
655		7	\|8 1\p \|0 (DE-588)4143413-4 \|a Aufsatzsammlung \|2 gnd-content
689	0	0	\|a Proteine \|0 (DE-588)4076388-2 \|D s
689	0	1	\|a Arzneimittel \|0 (DE-588)4003115-9 \|D s
689	0	2	\|a Arzneimittelstabilität \|0 (DE-588)4122835-2 \|D s
689	0	3	\|a Biopharmazie \|0 (DE-588)4006890-0 \|D s
689	0		\|8 2\p \|5 DE-604
689	1	0	\|a Proteine \|0 (DE-588)4076388-2 \|D s
689	1	1	\|a Arzneimittel \|0 (DE-588)4003115-9 \|D s
689	1	2	\|a Abbaureaktion \|0 (DE-588)4136352-8 \|D s
689	1		\|8 3\p \|5 DE-604
700	1		\|a Kontermann, Roland \|e Sonstige \|4 oth
912			\|a ZDB-30-PAD
999			\|a oai:aleph.bib-bvb.de:BVB01-029569017
883	1		\|8 1\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 2\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 3\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk

Datensatz im Suchindex

_version_	1804177274037075968
any_adam_object
building	Verbundindex
bvnumber	BV044162172
collection	ZDB-30-PAD
contents	pt. 1. General information -- pt. 2. Half-life extension through chemical and post-translational modifications -- pt. 3. Half-life modulation involving recycling by the neonatal Fc receptor -- pt. 4. Half-life extension with pharmaceutical formulations
ctrlnum	(ZDB-30-PAD)EBC851166 (ZDB-89-EBL)EBL851166 (OCoLC)775871780 (DE-599)BVBBV044162172
dewey-full	615.3
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	615 - Pharmacology and therapeutics
dewey-raw	615.3
dewey-search	615.3
dewey-sort	3615.3
dewey-tens	610 - Medicine and health
discipline	Medizin
format	Electronic eBook
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02411nmm a2200565zc 4500</leader><controlfield tag="001">BV044162172</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr\|uuu---uuuuu</controlfield><controlfield tag="008">170217s2012 \|\|\|\| o\|\|u\| \|\|\|\|\|\|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527328499</subfield><subfield code="9">978-3-527-32849-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527644797</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-527-64479-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC851166</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL851166</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)775871780</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044162172</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.3</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapeutic proteins</subfield><subfield code="b">strategies to modulate their plasma half-lives</subfield><subfield code="c">edited by by Roland Kontermann</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim, Germany</subfield><subfield code="b">Wiley-Blackwell</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xviii, 354 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">pt. 1. General information -- pt. 2. Half-life extension through chemical and post-translational modifications -- pt. 3. Half-life modulation involving recycling by the neonatal Fc receptor -- pt. 4. Half-life extension with pharmaceutical formulations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein drugs</subfield><subfield code="x">Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteins</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Abbaureaktion</subfield><subfield code="0">(DE-588)4136352-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelstabilität</subfield><subfield code="0">(DE-588)4122835-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Abbaureaktion</subfield><subfield code="0">(DE-588)4136352-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kontermann, Roland</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029569017</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection>
genre	1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet	Aufsatzsammlung
id	DE-604.BV044162172
illustrated	Not Illustrated
indexdate	2024-07-10T07:45:28Z
institution	BVB
isbn	9783527328499 9783527644797
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-029569017
oclc_num	775871780
open_access_boolean
physical	xviii, 354 p.
psigel	ZDB-30-PAD
publishDate	2012
publishDateSearch	2012
publishDateSort	2012
publisher	Wiley-Blackwell
record_format	marc
spelling	Therapeutic proteins strategies to modulate their plasma half-lives edited by by Roland Kontermann Weinheim, Germany Wiley-Blackwell 2012 xviii, 354 p. txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index pt. 1. General information -- pt. 2. Half-life extension through chemical and post-translational modifications -- pt. 3. Half-life modulation involving recycling by the neonatal Fc receptor -- pt. 4. Half-life extension with pharmaceutical formulations Protein drugs Design Proteins Therapeutic use Proteine (DE-588)4076388-2 gnd rswk-swf Arzneimittelstabilität (DE-588)4122835-2 gnd rswk-swf Biopharmazie (DE-588)4006890-0 gnd rswk-swf Abbaureaktion (DE-588)4136352-8 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Proteine (DE-588)4076388-2 s Arzneimittel (DE-588)4003115-9 s Arzneimittelstabilität (DE-588)4122835-2 s Biopharmazie (DE-588)4006890-0 s 2\p DE-604 Abbaureaktion (DE-588)4136352-8 s 3\p DE-604 Kontermann, Roland Sonstige oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk
spellingShingle	Therapeutic proteins strategies to modulate their plasma half-lives pt. 1. General information -- pt. 2. Half-life extension through chemical and post-translational modifications -- pt. 3. Half-life modulation involving recycling by the neonatal Fc receptor -- pt. 4. Half-life extension with pharmaceutical formulations Protein drugs Design Proteins Therapeutic use Proteine (DE-588)4076388-2 gnd Arzneimittelstabilität (DE-588)4122835-2 gnd Biopharmazie (DE-588)4006890-0 gnd Abbaureaktion (DE-588)4136352-8 gnd Arzneimittel (DE-588)4003115-9 gnd
subject_GND	(DE-588)4076388-2 (DE-588)4122835-2 (DE-588)4006890-0 (DE-588)4136352-8 (DE-588)4003115-9 (DE-588)4143413-4
title	Therapeutic proteins strategies to modulate their plasma half-lives
title_auth	Therapeutic proteins strategies to modulate their plasma half-lives
title_exact_search	Therapeutic proteins strategies to modulate their plasma half-lives
title_full	Therapeutic proteins strategies to modulate their plasma half-lives edited by by Roland Kontermann
title_fullStr	Therapeutic proteins strategies to modulate their plasma half-lives edited by by Roland Kontermann
title_full_unstemmed	Therapeutic proteins strategies to modulate their plasma half-lives edited by by Roland Kontermann
title_short	Therapeutic proteins
title_sort	therapeutic proteins strategies to modulate their plasma half lives
title_sub	strategies to modulate their plasma half-lives
topic	Protein drugs Design Proteins Therapeutic use Proteine (DE-588)4076388-2 gnd Arzneimittelstabilität (DE-588)4122835-2 gnd Biopharmazie (DE-588)4006890-0 gnd Abbaureaktion (DE-588)4136352-8 gnd Arzneimittel (DE-588)4003115-9 gnd
topic_facet	Protein drugs Design Proteins Therapeutic use Proteine Arzneimittelstabilität Biopharmazie Abbaureaktion Arzneimittel Aufsatzsammlung
work_keys_str_mv	AT kontermannroland therapeuticproteinsstrategiestomodulatetheirplasmahalflives

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand!

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge